Aims: Hippocampus is the brain center for memory formation, a process that requires synaptogenesis. However, hippocampus is dramatically compromised in Alzheimer's disease due to the accumulation of amyloid b-peptide, whose production is initiated by b-site APP Cleaving Enzyme 1 (BACE1). It is known that pathological stressors activate BACE1 translation through the phosphorylation of the eukaryotic initiation factor-2a (eIF2a) by GCN2, PERK, or PKR kinases, leading to amyloidogenesis. However, BACE1 physiological regulation is still unclear. Since nitric oxide (NO) participates directly in hippocampal glutamatergic signaling, we investigated the neuronal role of the heme-regulated eukaryotic initiation factor eIF2a kinase (HRI), which can bind NO by a heme group, in BACE1 translation and its physiological consequences. Results: We found that BACE1 is expressed on glutamate activation with NO being the downstream effector by triggering eIF2a phosphorylation, as it was obtained by Western blot and luciferase assay. It is due to the activation of HRI by NO as assayed by Western blot and immunofluorescence with an HRI inhibitor and HRI siRNA. BACE1 expression was early detected at synaptic spines, contributing to spine growth and consolidating the hippocampal memory as assayed with mice treated with HRI or neuronal NO synthase inhibitors. Innovation: We provide the first description that HRI and eIF2a are working in physiological conditions in the brain under the control of nitric oxide and glutamate signaling, and also that BACE1 has a physiological role in hippocampal function. Conclusion: We conclude that BACE1 translation is controlled by NO through HRI in glutamatergic hippocampal synapses, where it plays physiological functions, allowing the spine growth and memory consolidation. Antioxid. Redox Signal. 22, 1295-1307.
Introduction

L
earning and memory are brain functions performed by the hippocampus. These functions are dramatically compromised in Alzheimer's disease (AD) due to the extracellular deposition of the neurotoxic amyloid b-peptide (Ab) in the hippocampus (26) .
BACE1 is the rate-limiting step in the genesis of Ab but it also cleaves physiological substrates involved in the regulation of axonal myelination, membrane excitability, and neurite length (20, 39) , which would provide a physiological explanation for the existence of such an enzyme. BACE1 mouse knockout (KO) presents no serious abnormalities (24) , although these animals show alterations in hippocampal synaptic plasticity as well as in performance on tests of cognition and emotion (22) .
The limiting step that controls BACE1 expression is translation. BACE1 mRNA contains a 5¢-untranslated region (UTR) that represses translation under basal conditions (23) . BACE1 5¢UTR is 570 nucleotides long, contains four upstream initiation codons (uAUGs), and possesses a rich GC content. These features prevent the ribosome from reaching the main open reading frame to start BACE1 protein synthesis. Therefore, BACE1 translation is minimal under basal conditions. Paradoxically, BACE1 translation is activated when global protein translation is inhibited through the phosphorylation of the eukaryotic initiation factor-2a (eIF2a) at Serine 51 (29) .
There are four different eIF2a kinases: the double-stranded RNA-activated protein kinase (PKR), the PKR-like endoplasmic reticulum-related kinase (PERK), the general control nonderepressible-2 kinase (GCN2), and the Heme-regulated eukaryotic initiation factor eIF2a kinase (HRI) (9) . Some studies show that cellular stress associated with AD neurodegeneration stimulates BACE1 translation through the activation of a specific eIF2a kinase and the consequent eIF2a phosphorylation, resulting in a burst of Ab production that would trigger sporadic AD (18, 28, 29) .
In the hippocampal synapses, glutamate opens the NMDA receptor, producing a calcium influx that activates the nitric oxide (NO) neuronal synthase (nNOS), releasing NO. Since HRI has been previously reported to respond to NO in reticulocytes and erythrocytes (27, 37) and there is evidence of HRI function in the hippocampus (17) , here we addressed the study of the role of NO in the physiological regulation of BACE1 translation by HRI activation.
Results
Nitric oxide induces eIF2a phosphorylation and BACE1 translation at synapses BACE1 expression is activated by glutamate treatment for 1 h in hippocampal neurons (Fig. 1A) . To restrict our study to the synaptic area, we stimulated mouse synaptosomes ( Fig.  1B ) with glutamate for 1 h (Fig. 1C) . We found a significant increase in BACE1 protein (Fig. 1C, D) and phosphorylated eIF2a (Fig. 1C, E) . Co-treatment with 7-NI (an nNOS inhibitor [NOS-i]) inhibited this effect ( Fig. 1C-E) , suggesting that eIF2a phosphorylation and BACE1 expression were NO dependent. This was confirmed by treating synaptosomes with increasing concentrations of the NO donor sodium nitroprusside (SNP) for 1 h (Fig. 1F-H) . The same results were obtained with primary cultures of cortical neurons (Supplementary Fig. S1 ; Supplementary Data are available online at www.liebertpub.com/ars).
The rapid increase (Dt £ 1 h) in BACE1 expression and eIF2a phosphorylation in response to stimulation with NO suggested a translational activation from a pre-existing BACE1 mRNA rather than de novo transcription of BACE1 gene. We studied the possible transcriptional effect of NO and glutamate on BACE1 mRNA, and we did not observe any BACE1 mRNA increase ( Fig. 2A) . Furthermore, we challenged SH-SY5Y cells with cycloheximide (a translation inhibitor) to demonstrate the translational regulation of BACE1 on NO stimulation and as it was expected, the effect of NO on BACE1 expression was abolished in the presence of cycloheximide (Fig. 2B ). The use of anucleated preparations such as synaptosomes reinforced the view that BACE1 upregulation was due to a nucleus-independent post-transcriptional event.
BACE1 has four AUGs in the 5¢UTR (Fig. 3A) , which are directly involved in the basal repression of its translation (23) . To demonstrate that the effect of NO on BACE1 expression was due to a translational mechanism involving eIF2a phosphorylation, we cloned BACE1 5¢UTR upstream of a luciferase reporter gene (Fig. 3A) and confirmed its inhibitory effect on translation. This translational repression was overcome by mutating the 5¢UTR (changing its four ATG by TTG) or using Sal003, a drug that selectively inhibits eIF2a dephosphorylation (Fig. 3B) . In Figure 3C , it is shown that the treatment of the 5¢UTR-luciferase construct (5¢UTR-luc)-transfected cells with high concentrations of SNP for 1 h reproduced the stimulatory effect induced by the mutated 5¢UTR over BACE1 5¢UTR, suggesting that NO stimulates the translation of BACE1 mRNA through the phosphorylation of eIF2a.
HRI kinase is required to activate BACE1 translation in response to NO Among the four existing eIF2a kinases in the mammalian genome, only HRI induces eIF2a phosphorylation on direct activation by NO (37) . Therefore, we studied the expression of HRI mRNA and protein in human hippocampus, mouse hippocampal neurons, and human neuroblastoma cells. We have discovered that both HRI mRNA and protein are present in all the tissues and cells studied (Fig. 4A, B) . We also found that HRI colocalized with the postsynaptic marker PSD95 in the synaptic spines (Fig. 4C) , as well as p-eIF2a (Supplementary Fig. S2 ).
To study the role of HRI in eIF2a phosphorylation and BACE1 expression, we used both a specific HRI inhibitor (HRI-i) (32) and a small interfering HRI RNA (siHRI), knocking down HRI expression in vitro (Supplementary Fig.  S3A ). SH-SY5Y cells preincubated with the HRI-i failed to respond to NO and neither overexpressed BACE1 nor increased the levels of phosphorylated eIF2a (Fig. 5A-C) . On Innovation BACE1 (b-secretase-1) is the key enzyme producing amyloid b-peptide (Ab) that causes Alzheimer's disease, but its physiological role is practically unknown. BACE1 knockout mice were reported to have problems in memory and learning and here we found that BACE1 is allowing hippocampal spine growth and memory consolidation. Moreover, we have found that BACE1 translation in the hippocampal glutamatergic synapses is mediated by the enzyme heme-kinase HRI, on activation of nitric oxide, which phosphorylates the initiation factor eukaryotic initiation factor-2a (eIF2a). the other hand, the same activation on BACE1 expression was obtained with two different NO donors, CysNO and GSNO ( Supplementary Fig. S4 ).
Similarly, when HRI expression was knocked down by a specific siRNA, NO did not upregulate BACE1 protein (Fig.  5D) . Similar results were also obtained by using Noc7, another NO donor ( Supplementary Fig. S3B ). Consistent with these in vitro findings, NOS-i and HRI-i administered chronically to mice for 1 week induced a significant reduction in the levels of BACE1 and phospho-eIF2a in the synaptosomes isolated from their hippocampi (Fig. 5E-G) .
To demonstrate the specificity of the NO-HRI-eIF2a in our experiments, we challenged the NO donor in mouse embryonic fibroblast (MEF) cells with a Serine 51 to Alanine substitution in the eIF2a, the phosphorylation residue. Hence, we studied the BACE1 levels after the SNP treatment in the eIF2a-SS MEF cells (the homozygous wild-type) and in the eIF2a-AA MEF cells (the homozygous mutant) (Supplementary Fig. S5A ). Since eIF2a can be also phosphorylated by other kinases (PKR, PERK, and GCN2), we have demonstrated in KO MEF cells for each of these kinases that NO induces the expression of BACE1. This expression is depending on HRI, as it was also demonstrated with HRI KO cells or by using HRI-i in the other eIF2a-kinase KO MEF cells (Supplementary Fig. S5B ).
On the other hand, we treated SH-SY5Y cells with increasing concentrations of the cGMP analog dibutyryl-cyclic GMP (dbcGMP) and observed no stimulatory effect on BACE1 expression ( Supplementary Fig. S6 ), ruling out the possibility of participation of the classical NO/sGC/cGMP pathway in the NO-induced BACE1 upregulation.
NO induces the translation of an active BACE1 protease
In Figure 6 , we addressed whether the rapid translational activation of BACE1 induced by NO would result in an active BACE1 protease. We stimulated HEK-APPsw cells with SNP for 1 h and collected the medium for Ab determination as an indicator of BACE1 activity (Fig. 6A, B) . We found that both Ab and Ab 1-42 isoforms were increased after treatment with increasing concentrations of SNP for 1 h, supporting the fact that BACE1 translation is rendering the active enzyme. To confirm the exclusive role of BACE1 in Ab increase induced by NO, we stimulated ADAM10 KO MEFs with SNP and observed an increase in APP C-terminal fragment (APP CTF) that correlated with a substantial increase in BACE1 expression (Fig. 6C) , suggesting a role of BACE1 protease in the Ab increase induced by NO signaling (Fig. 6A, B) . Similarly, PS1/PS2 db-KO MEFs responded to Fig. S7 ) that can be due to an increased BACE1 activity over APP. Concomitant with the enhancement in Ab production due to BACE1 activity, we observed that the levels of secreted soluble APPa (sAPPa), a product of a-secretase cleavage, decreased gradually after stimulation with SNP in HEK-APPsw cells versus the total levels of APP (holo APP) (Fig. 6D ).
HRI colocalizes with BACE1 at dendritic spines in response to NO Synaptic plasticity in the hippocampal glutamatergic neurons occurs at dendritic spines, allowing their growth. The NMDA receptors and all the downstream molecules involved in hippocampal function are located in the dendritic spines to allow a rapid expression of the needed proteins. We confirmed the increase of synaptic markers in hippocampal cells in response to the NO donor SNP, a specific regulation that was avoided in the presence of HRI-i (Fig. 7A ). We found that BACE1 expression increased at dendritic spines, colocalizing partially with PSD95 as was shown by immunofluorescence analysis and Mander's coefficient quantification (Fig. 7B, C) . We also found that the activation of HRI induced spine growth as the ratio spine number/spine size increased after stimulation with SNP as shown in Figure 7D . This effect was prevented by preincubating the cells with the HRI-i but not with the PKR inhibitor (PKR-i) (Fig. 7D) . Furthermore, a classical antioxidant such as reduced glutathione (GSH) did not affect the levels of BACE1 induced by glutamate in hippocampal cells ( Supplementary Fig. S8A ).
To confirm this lack of activity of oxidative stress in our results, we have challenged the cells with the oxidative stressor hydrogen peroxide, an activator of PKR, and did not observe any effect in spine growth ( Supplementary Fig. S8B ).
HRI is essential for memory consolidation in mice
To further study the in vivo relevance of the NO/HRI pathway in cognitive processing, we administered intraperitoneally (i.p.) inhibitors for HRI and NOS during the memory consolidation period as shown in Figure 8 . First, we showed by Western blot from hippocampi of the treated mice the decrease on BACE1 and p-eIF2a when mice were treated with HRI-i (Fig. 8A ). In the cognitive study, we used two paradigms involving hippocampal processing: the objectrecognition test (Fig. 8B ) and the context-recognition test (Fig. 8C ). Mice receiving HRI-i or NOS-i showed a memory impairment in the object recognition ( Fig. 8B ), without affecting their exploratory behavior (inset in Fig. 8B ). Similarly, context-recognition memory was significantly compromised by both inhibitors (Fig. 8C ).
Discussion
Hippocampus is the main center for memory formation, where NO plays a key role in glutamatergic signaling (12, 35, 40) . However, hippocampus is one of the most affected brain structures in AD because of the high load of Ab, due to the deregulation of BACE1 activity, that induces a dramatic memory impairment of aggregates (19, 26) . Currently, the physiological role of BACE1 in the hippocampus is practically unknown. In this work, we report that the enzyme HRI is activated by NO in hippocampal neurons, contributing to synaptogenesis through BACE1 expression.
Glutamatergic signaling is characterized by a postsynaptic burst in NO, which acts as a retrograde gaseous neurotransmitter (2) with an important role in long-term potentiation and memory formation (12, 35, 40) due to the maintenance of hippocampal glutamatergic release at the presynaptic ending. Among the four existing eIF2a kinases (9), only HRI induces eIF2a phosphorylation on direct activation by NO (37) . HRI was first identified in rabbit reticulocytes (27) , where it participates in the regulation of hemoglobin synthesis according to heme availability (4) . In this context, the lack of heme activates HRI (9), leading to a translational arrest that avoids the synthesis of defective hemoglobin. HRI is activated by NO binding to the heme group in the N-terminus of the kinase (36). The structural details of the NO-mediated activation of HRI have been identified (15) , resulting in a mechanism similar to that of the canonical NO/sGC pathway since both enzymes share a heme group (16) . The effector domain of HRI catalyzes the eIF2a phosphorylation. The phosphorylation of eIF2a leads to an arrest of global protein synthesis. Nevertheless, neuron terminals have highly compartmentalized environments. Therefore, eIF2a phosphorylation occurs far away from the neuron soma without any consequence in the neuron somatic metabolism, and only temporarily altering the translational profile at synaptic sites, an effect that can be easily delimited by the action of eIF2a phosphatases. Translational control is a crucial mechanism in highly polarized cells such as neurons, where mRNAs are distributed asymmetrically at different subcellular locations. In neurons, new protein synthesis is needed at active synaptic sites. Translational control of mRNAs located at synaptic sites allows rapid and specific genetic changes in a given synapse, in a process referred to as ''input specific synaptic remodeling.'' However, the nature of the intracellular signals that couple neurotransmitter to the translational machinery is currently unknown. In that regard, we propose that NO can control translational initiation through direct activation of HRI kinase.
Furthermore, the phosphorylation of eIF2a has been shown to be a critical event in long-term memory formation (7) . Interestingly, HRI has been recently proposed to mediate memory consolidation in mice (17), as we have also found in this work regarding BACE1 activation as a downstream effect of HRI activation. We have found that NO-HRI-eIF2a signaling induces BACE1 translation. We used SNP as an NO donor, because it mimics the NO burst produced by NOS activation; however, a decrease in BACE1 expression has been previously reported by using the NO donor CysNO (21, 33) . These controversial results would be related with the different cell types used in the cited work, since we have also obtained an increase in BACE1 when hippocampal neurons were treated with CysNO.
BACE1 mRNA is present in dendritic spines of hippocampal pyramidal neurons (34) and contains two cytoplasmic polyadenylation elements and accessory sequences in its long 3¢UTR that target mRNAs to dendrites, where they are translated on adequate stimulation (14) . It allows having a constitutive pool of BACE1 mRNA at postsynaptic ending while its regulation is carried out at translational level due to eIF2a kinases (18, 29, 30) .
BACE1 translation by NO action produces an active enzyme, which agrees with previous reports showing that basal synaptic activity produces Ab (6). We found that HRI controls BACE1 expression and both enzymes are located at dendritic spines. A strict physiological regulation of BACE1 protein expression, whose levels are aberrantly upregulated in sporadic AD (13) , might explain the participation of BACE1 in synaptic plasticity and memory formation as a rapid mechanism to allow the cleavage of APP (25) (Supplementary Fig. S9A ). We hypothesize that the NO-mediated BACE1 increase at synapses is directed toward lowering the adhesion force of neuritic terminals to the extracellular matrix through the cleavage of APP. Since APP is a cell adhesion molecule (5, 8) , localized cleavage of APP would imply a reduction in the dendritic attachment that allows synaptic growth and rearrangement. In fact, memory formation requires synaptic structural changes (1) . An effect of BACE1 in the shedding of other proteins needed for neuronal function (20, 39) , besides APP cleavage, is also completely plausible but far for the main aim of our work. The NO-HRI-eIF2a pathway in glutamatergic signaling should have other key targets, such as the CREB repressor ATF4 (CREB2) (11, 17) , which are critical for hippocampal function. In recent years, an increased number of papers have reported a role for hippocampal BACE1 protein in memory consolidation. Furthermore, here and in a previous work, we identified that hippocampal HRI kinase is a necessary player in the consolidation of object-recognition memory, a process in which HRI regulates hippocampal BACE1 expression (17) .
In pathological events involving oxidative stress such as AD, two parallel events take place in relation to NO. First, there is a loss in NO bioavailability due to the reaction with superoxide anion to form peroxynitrite (19) ; therefore, its physiological effects in memory formation and neuronal plasticity are dramatically reduced. Second, peroxynitrite triggers the initiation of a harmful nitrative cascade (19) . In this pathological scenario, the tight regulation of BACE1 translation by NO-HRI-eIF2a is lost but the other eIF2a kinases (PKR, PERK, and GCN2), which are stress sensors, will be permanently activated to induce BACE1 expression in an uncontrolled way, yielding to the phosphorylation of eIF2a, which initiates the amyloid cascade that triggers AD (Supplementary Fig. S9B ).
In conclusion, we propose NO as the physiological activator of BACE1 translation in synapses on HRI activation, which it critical to allow synaptogenesis and memory consolidation. As the signaling pathway initiated by NO transduces the signal through the phosphorylation of eIF2a, and eIF2a phosphorylation is an important homeostatic response to cellular stress, our findings could help understand the opposing effects in which BACE1 is involved.
Materials and Methods
Human hippocampal samples
Human hippocampal samples were supplied by the Banc de Teixits Neurològics (Serveis Científico-Tècnics, Hospital Clínic, Universitat de Barcelona). The procedure was approved by the ethics committee of the Institut Municipal d'Investigacions Mèdiques-Universitat Pompeu Fabra. The hippocampus from a healthy aged individual was lysated with a cocktail containing NP40 lysis buffer (150 mM NaCl, 5 mM EDTA, 1% Nonidet P-40, 1 mM sodium orthovanadate, 1 mM phenylmethylsulphonyl fluoride, 0.05% aprotinin, 1 mM dithioltreitol) and protease inhibitors (Complete mini-EDTA free; Roche Diagnostics GmbH). The mix was mechanically disaggregated and centrifuged at 17,500 g for 10 min. The supernatant was quantified by the bicinchoninic acid (BCA, Pierce BCA Protein assay kit; Thermo Scientific) assay.
Cell cultures
Hippocampal and cortical neurons were isolated from 18-day-old CB1 mouse and Wistar rat embryos. Mice and rats were anesthetized with 20 mg/kg xilacina plus 100 mg/kg ketamina and sacrificed. The procedure was approved by the Ethics Committee of the Institut Municipal d'Investigacions Mediques-Universitat Pompeu Fabra. Hippocampi were aseptically dissected and trypsinized. Cells were seeded in phenol-red-free Dulbecco's modified Eagle's medium (DMEM; Sigma-Aldrich) plus 10% horse serum into 1% poly-l-Lysine-coated coverslips (5 · 10 4 cells/cover). After 120 min, the medium was removed and neurobasal medium containing 1% B27 supplement (Gibco BRL) plus antibiotics (100 units/ml penicillin and 100 mg/ml streptomycin) was added. Glial proliferation was avoided by adding 2 lM cytosine arabinoside (Sigma-Aldrich) at day 3 for 24 h. Cultured hippocampal and cortical neurons were used for the experiments on day 7. Human neuroblastoma cells (SH-SY5Y) were grown with F-12 (Ham) supplemented with 15% fetal bovine serum (FBS) and antibiotics. HEK cells overexpressing the Swedish mutation of APP (HEK-APPsw cells), which enhances its cleavage by BACE1, were grown with DMEM supplemented with 10% FBS and antibiotics. MEFs that lacked either ADAM10 (ADAM10 KO MEFs) or the a-secretase were grown with DMEM/F12 containing 10% FBS and antibiotics. Cells were incubated at 37°C in a humidified atmosphere of 5% CO 2 . Cells were incubated at 37°C in a humidified atmosphere of 5% CO 2 .
Preparation of cortical and hippocampal synaptosomes C57 mice were treated i.p. with 50 mg/kg of NOS-i (7-nitroindazole; Sigma-Aldrich) or 10, 50, and 100 mg/kg HRIi (N-2,6-dimethylbenzyl-6,7-dimethoxy-2H-benzofurol-3, 2-c-pyrazol-3-amine hydrochloride; Janssen Research and Development) and dimethyl sulfoxide (DMSO) as vehicle control in a volume of 2 ml/kg. HRI-i specificity was tested in a commercially available selectivity panel (EMD Millipore) of more than 100 kinase, enzyme, GPCR, and ion channel targets, and showed > 100-fold selectivity for HRI kinase versus these pharmacological loci (32) . After 24 h, mice were anesthetized with 20 mg/kg xilacina plus 100 mg/kg ketamina and sacrificed. Cortex and hippocampi were dissected. and 320 mM sucrose) and filtered. The homogenate was centrifuged at 1000 g at 4°C for 10 min. The supernatant was recovered, and sucrose buffer was added to a final sucrose concentration of 0.8 M. Samples were centrifuged at 13,000 g for 30 min at 4°C. The supernatant was discarded, and the synaptosome layer was separated from mitochondria by carefully adding 1 ml of ice-cold 320 mM sucrose buffer and gently shaking. Synaptosome fraction was diluted in Hank's balanced saline solution buffer to a final protein concentration of 1 mg/ml. Protein concentration was determined using Bio-Rad protein assay. The final synaptosome suspension was distributed in 1 ml aliquots to perform the experiments. Synaptosome integrity was assessed by electron microscopy.
HRI mRNA extraction and RT-PCR
RNA extraction (Nucleospin RNA II kit; MachereyNagel) from human hippocampus, primary cultures of mouse hippocampal neurons, and SH-SY5Y cells was carried out and RT-PCR was performed using SuperScrip-RT system (Invitrogen). Aliquots of 1 lg cDNA were used as a template for PCR. The primers used to amplify HRI from human were: 5¢-CCCCGAATATGACGAATCTG-3¢ and 5¢-CAGATTCG TCATATTCGGGC-3¢; the primers used to amplify HRI from mouse were: 5¢-GAAGTGGGTTTGGTTCATGC-3¢ and 5¢-GCATGAACCAAACCCACTTC-3¢. PCR conditions for all transcripts were: 95°C for 3 min; 95°C for 30 s; 60°C for 30 s; 72°C for 30 s; and 72°C for 7 min, along with 35 cycles of amplification. The amplified HRI was resolved in a 2% agarose gel.
HRI immunoprecipitation
Two hundred micrograms of homogenate human hippocampus, 200 lg of protein from primary cultures of mouse hippocampal neurons and SH-SY5Y cells were used for the immunoprecipitation. The samples were preincubated for 30 min at 4°C with protein G (GE Healthcare) and previously washed with phosphate-buffered saline (PBS). Then, samples were centrifuged at 10,000 g for 10 min. Overnight incubation of supernatants with 5 lg of rabbit anti-HRI antibody (Ab; Abcam) was followed by the addition of protein G immobilized on sepharose and shaken for 2 h at room temperature (RT). HRI was pulled down by centrifugation at 14,000 g for 10 min and washed thrice.
Cloning of BACE1 5¢UTR
Total RNA was extracted from SH-SY5Y cells, and onestep RT-PCR was carried out using a kit (Qiagen) with primers designed to amplify BACE1 5¢UTR: 5¢-GAAGCTT ACAAGTCTTTCCGCCTCCCC-3¢, 5¢-GAAGCTTGGTGG GCCCCGGCCTTC-3¢. PCR product, a single band matching the molecular weight of BACE1 5¢UTR (*500 nt), was isolated and purified from an agarose gel using the IlustraÔ GFXÔ PCR DNA and Gel Band Purification kit (GE Healthcare) and stored at -20°C for further use. The 5¢UTR DNA fragment was then inserted into the HindIII site of a modified pGL4.10 [luc2] vector from Promega containing the CMV promoter cloned at BglII and HindIII sites.
BACE1 mRNA analysis
SH-SY5Y were seeded in six-well plates and exposed to 100 nM SNP and 10 lM glutamate for 1 h. Total RNA was extracted using the Nucleospin RNA II kit (Macherey-Nagel) according to the manufacturer's instructions, and reverse transcription PCR was performed using SuperScrip-RT system (Invitrogen). Quantitative RT-PCR was performed on an ABI Prism 7900HT (Applied Biosystems) with SYBR-Green (SYBR-Green Power PCR Master Mix; Applied Biosystems) and the following primers: BACE1 5¢-CAA TGG ACA GGA TCT GAA AAT GG-3¢ and 5¢-GCC ACT GTC CAC AAT GCT CTT-3¢; GAPDH 5¢-GGA GTC CAC TGG CGT CTT C-3¢ and 5¢-TGG CTC CCC CCT GCA AAT G-3¢. GAPDH was used as a control. PCR conditions were: 95°C for 5 min; 95°C for 30 s; 60°C for 30 s; 72°C for 30 s; and 72°C for 5 min, along with 40 cycles of amplification. . Cells were transfected using JetPEI transfection reagent (PolyPlus) for 2 h. The medium was changed and the cells were incubated for 10 h to allow gene expression. Cells were treated with 100 lM of the inhibitor of p-eIF2a phospatase PP1 salubrinal (Sal003; Tocris) or the NO donor SNP (Sigma-Aldrich) for 1 h. 100 lM SNP provides a flow of 100 lM/min of NO (10) . Cells were lysed, luciferase and Renilla activities were measured by using the Dual-GloÔ Luciferase Assay System (Promega) following the manufacturer's instructions, and luminescence was read using a luminometer (Fluostar OPTIMA; BMG Labtech).
Treatments
Hippocampal neurons, cortical synaptosomes, SH-SY5Y cells, HEK-APPsw cells, ADAM10 KO MEFs, and PS1/PS2 db-KO MEFs were treated with glutamate (Sigma-Aldrich), SNP, cycloheximide, noc7, NOS-i, HRI-i, or PKR-i (Calbiochem).
Cells and synaptosomes were immediately harvested for WB analysis, fixed with 4% paraformaldehyde (PFA) for immunofluorescence or the medium was collected for Ab quantification and aAPPs identification.
Protein identification by Western blot
Cells and synaptosomes were lysed on ice with a solution containing 1 M Tris-HCl, 1% Nonidet P-40, 150 mM NaCl, 5 mM EDTA, 1 mM sodium orthovanadate, 1 mM dithiothreitol, pH 7.4, and a protease inhibitor cocktail (Roche). Protein concentration was determined by Bio-Rad protein assay in the homogenates and in the medium from HEKAPPsw cells. Aliquots of 80 lg of protein were loaded into 8% (for HRI immunoprecipitated) and 12% SDS-PAGE and transferred to polyvinylidene fluoride membranes (Immobilon-P; Millipore). Membranes were blocked in Tween 20-Tris buffer solution (TTBS; 100 mM Tris-HCl, 150 mM NaCl, pH 7.5) containing 5% milk and incubated over night at 4°C with 1:1000 rabbit anti-BACE1 Ab (Chemicon International), 1:500 rabbit anti-phospho-eIF2a (Ser51) Ab (Cell signaling), 1:500 mouse anti-eIF2a Ab (Cell signaling), 1:1000 rabbit anti-HRI, 1:500 rabbit anti-sAPPa (Abcam), 1:1000 mouse anti-BACE1 Ab (for the work with KO MEFs; Cell Signalling), 1:10,000 rabbit anti-APP B63 (kindly provided by Dr. Bart de Strooper, Leuven University, Belgium), 1:4000 mouse anti-actin Ab (Sigma-Aldrich), or 1:2500 rabbit anti-GADPH Ab (Cell Signaling). Primary Abs were diluted either in 5% skimmed milk-TTBS (anti-BACE1, antieIF2a, anti-HRI, anti-sAPPa, and anti-actin) or in 5% bovine serum albumin in TTBS (anti-phospho-eIF2a). Peroxidase- conjugated donkey anti-rabbit and anti-mouse Abs (GE Healthcare) were used as secondary Abs at 1:5000 for 1 h at RT. Bands were visualized with Super Signal (Pierce) and developed with the Quantity One system. Optical density analysis of the bands was carried out by Quantity One software.
Immunofluorescence assays
Murine hippocampal neurons (5 · 10 4 cells/coverslip) were seeded into 1% poly-l-Lysine. SH-SY5Y cells (4 · 10 4 cells/coverslip) were seeded on 1.5% gelatine coated 12 mm coverslips. After treatments, cells were fixed with 4% PFA, permeabilized with 0.1% Triton X-100, and incubated for 2 h at RT in a hydration chamber with 1:100 rabbit anti-BACE1 Ab, 1:100 phospho-eIF2a (Ser 51) Ab, 1:500 rabbit anti-HRI Ab, 1:200 mouse anti-PSD95 (Abcam), or 1:200 mouse antib3tubulin tuj1 (Covance). After primary Ab, cells were incubated with 1:700 Alexa Fluor 555 goat anti-rabbit Ab (Life Technologies) and/or 1:700 Alexa Fluor 488 goat anti-mouse Ab (Life Technologies) for 1 h at RT. Nuclei were stained with 1:1000 TO-PRO 3 iodide (Sigma-Aldrich) in PBS for 10 min before mounting. Digital images were taken with a Leica TCS SP confocal microscope and analyzed with Leica confocal software. For colocalization experiments, primary Ab was tested with its counter secondary Ab to discard any cross-reactivity between rabbit and mouse isotypes.
Ab measurement
The medium from HEK-APPsw cells was replaced by experimental medium (phenol-red-free DMEM containing 4.5 g/L d-glucose, l-glutamine, and 25 mM HEPES) plus antibiotics and supplemented with 0.2% FBS. After 1 h of SNP treatment, 800 ll of medium were collected and centrifuged at 16,000 g for 5 min to eliminate cellular debris. Solid-phase sandwich ELISA kits containing two highly specific Ab for detection of the Ab peptides were used by following the manufacturer's instructions to measure human Ab and Ab (IBL Codes). The absorbance at 450 nm was determined for each sample. Data are expressed as percentages of the value for untreated cells.
Mander's coefficient measurement
Mander's coefficients were calculated in the experiments of colocalization of BACE1 and PSD95 in the synaptic spines from primary cultures of rat embryo hippocampal cells. Mander's coefficients measure the overlap of two different immunofluorescence channels (green and red stainings for BACE1 and PSD95, respectively in our experiments), showing the percentage of molecules stained with different colors that share the same location. Therefore, we calculated the overlapping of the green channel (BACE1) with the red channel (PSD95) as previously described (31) . It is expressed in arbitrary units from 0 to 1, with 0 being a lack of overlapping and 1 being the maximum of overlapping.
Object-recognition task. C57 mice were trained and tested in the V-maze for object-recognition memory, as previously described (3) . After the training session, mice were injected i.p. with NOS-i (50 mg/kg), HRI-i (10 or 50 mg/kg), or vehicle (DMSO) in a volume of 2 ml/kg. Object-recognition memory was tested 24 h later, and a discrimination index was calculated based on the time of exploration for novel and familiar objects in the test session, as previously described (3). Object-recognition exploration times from animals (treated with HRI-i or NOS-i as indicated earlier) were studied as previously described (3) to discard behavioral disorders.
Context-recognition task. C57 mice were trained and tested in conditioning chambers (Panlab) as previously described (3). Briefly, after electric foot shock conditioning, mice were injected i.p. with HRI-i (10 or 50 mg/kg), NOS-i (50 mg/kg), or vehicle (DMSO) in a volume of 2 ml/kg, and their freezing behavior was analyzed 24 h later, during a 3 min re-exposure to the same conditioning chamber.
Statistical analysis
Data were expressed as the mean -standard error of the mean of the values from the number of experiments as indicated in the corresponding figures. Data were evaluated statistically by using the Student's t-test. Memory tests were evaluated statistically by using one-way ANOVA followed by Bonferroni's post hoc analysis.
